KR870004026A - 피페라지노 이소티아졸론의 제조방법 - Google Patents

피페라지노 이소티아졸론의 제조방법 Download PDF

Info

Publication number
KR870004026A
KR870004026A KR1019860008685A KR860008685A KR870004026A KR 870004026 A KR870004026 A KR 870004026A KR 1019860008685 A KR1019860008685 A KR 1019860008685A KR 860008685 A KR860008685 A KR 860008685A KR 870004026 A KR870004026 A KR 870004026A
Authority
KR
South Korea
Prior art keywords
formula
compound
salt
reacting
halo
Prior art date
Application number
KR1019860008685A
Other languages
English (en)
Other versions
KR900000371B1 (ko
Inventor
압델-매기드 아보우-가르비아 매기드
알란 쉬서 가이
줄리어스 챠일드레스 스코트
Original Assignee
죠지 드 모트
아메리칸 홈 프로덕츠 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죠지 드 모트, 아메리칸 홈 프로덕츠 코포레이션 filed Critical 죠지 드 모트
Publication of KR870004026A publication Critical patent/KR870004026A/ko
Application granted granted Critical
Publication of KR900000371B1 publication Critical patent/KR900000371B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

피페라지노 이소티아졸론의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. (a) 일반식(A)의 사이클릭아민 또는 이의염을 일반식 R8-Y(여기서, R8는 하기에서 정의되는 일반식(B)의 그룹이다)의 화합물과 반응시켜 알킬화함으로써 일반식(B)의 치환된 알킬그룹을 도입하거나; (b) 일반식(A)의 사이클릭아민 또는 이의염을 일반식(C)의 알데하이드와 환원성 알킬화하거나; (C)일반식 (D)의 화합물 또는 이의염을 일반식(E1)의 화합물 또는 양이온 E2를 함유하는 화합물과 반응시키거나; (d) 일반식(F)의 화합물 또는 이의염을 (i) 일반식 (G),(H),(J),(K),(L1) 또는 (L2)의 화합물과 반응시켜 디엘스-알더반응(Diels-Alder reaction)시키거나 (ii) 에폭시화하거나 (iii)카벤을 삽입하거나 (iv) 질소 잔기를 삽입하여 일반식(N)의 아지리딘 또는 이의 염을 형성하거나; (e) 일반식(M)의 화합물 또는 이의 염을 적합한 질소 친핵제와 반응시켜 옥시란환을 개환한 다음, 생성된 중간체를 일반식(N)의 아지리딘 또는 이의 염으로 전환시키거나; (f) 일반식(F)의 화합물 또는 이의 염을 일반식 O=C=CR3R4(여기서, R3및 R4는 하기에서 정의되는 바와 같다)의 커텐과 반응시켜 일반식(P)의 화합물 또는 이의 염을 제조하거나; (g) 일반식(P)의 화합물 또는 이의 염을 환원시켜 일반식(Q)의 화합물 또는 이의 염을 제조하거나; (h)일반식(R)의 화합물 또는 이의 염으로부터 설핀산을 제거하거나; (j)일반식(I)에 따른 에틸렌성 불포화 화합물 또는 이의 염을 환원시켜 이의 포화 동족체를 형성하거나; (K)일반식(I)의 화합물에 산을 가하여 이의 산부가염으로 전환시키거나, 일반식(Ⅰ)의 화합물의 산부가염을 중화시켜 일반식(Ⅰ)의 화합물을 형성함을 특징으로 하여 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 이의염을 제조하는 방법.
    상기식에서 R1및 R2는 각각 독립적으로 수소, 저급알킬, 아릴 또는 할로이거나, 이들은 함께 -CH2-, -CH2CH2-, -O-, -NH-,
    -CH=CH-S, =CH-S-CH=, -S-CH=CH-,
    를 나타내고, R3,R4,R5및 R6는 각각 독립적으로 수소, 저급알킬, 아릴 또는 할로이며, R7는 2-피리디닐, 2-피리미디닐, 2-피라지닐, 3-피리다지닐 또는 페닐이거나, 저급알킬, 트리플루오로메틸, 시아노, 니트로 또는 할로에 의해 치환된 2-피리디닐, 2-피리미디닐, 2-피라지닐, 3-피리다지닐 또는 페닐중의 하나 [단, R1및 R2가 함께 다음 일반식(Ⅳ)를 나타낼때, R7는 2-피리디닐, 2-피리미디닐 또는 치환된 피리미딘-2-일이 아니다.
    ]이고,
    R9는 유기술포닐그룹, 예를 들어, 메틸술포닐이며, X는 저급 알킬렌, 비닐렌, O 또는 NH이고, Y는 이탈그룹, 예를 들어, 클로로 또는 브로모와 같은 할로원자이며; Z는 -(CH2)n- [여기서, n은 0내지 4이다],
    비닐렌, -O-, 또는이고;
    m은 2내지 5[단, 일반식(E2)에서 m은 2내지 4이다]이며; O는 1내지 3[단, 일반식(E2)에서 O는 2또는 3이다]이고; P는 1내지 4이며, 점선은 임의의 이중결합을 나타낸다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860008685A 1985-10-17 1986-10-16 피페라지노이소티아졸론 및 이의 제조방법 KR900000371B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US78831585A 1985-10-17 1985-10-17
US788315 1985-10-17
US06/893,507 US4732984A (en) 1985-10-17 1986-08-05 Piperazinoisothiazolones with psychotropic activity
US893507 1986-08-05

Publications (2)

Publication Number Publication Date
KR870004026A true KR870004026A (ko) 1987-05-07
KR900000371B1 KR900000371B1 (ko) 1990-01-25

Family

ID=27120784

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860008685A KR900000371B1 (ko) 1985-10-17 1986-10-16 피페라지노이소티아졸론 및 이의 제조방법

Country Status (12)

Country Link
US (1) US4732984A (ko)
EP (1) EP0220051B1 (ko)
KR (1) KR900000371B1 (ko)
AU (1) AU603776B2 (ko)
CA (1) CA1272197A (ko)
DE (1) DE3679767D1 (ko)
DK (1) DK495586A (ko)
ES (1) ES2039200T3 (ko)
GB (1) GB2181730B (ko)
GR (1) GR3002635T3 (ko)
HU (1) HU206344B (ko)
PT (1) PT83548B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4797488A (en) * 1987-04-03 1989-01-10 American Home Products Corporation Psychotropic polycyclic imides
US4804751A (en) * 1987-06-30 1989-02-14 American Home Products Corporation Polycyclic hydrocarbon succinimides with psychotropic activity
ATA39088A (de) 1988-02-18 1990-06-15 Binder Dieter Dr Basisch substituierte thienoisothiazol-3(2h)-on-1,1-dioxide und ihre pharmazeutisch vertraeglichen salze, verfahren zu ihrer herstellung und ihre verwendung
WO1990002552A1 (en) * 1988-09-16 1990-03-22 Pfizer Inc. Antipsychotic 4-[4-(3-benzisothiazolyl)-1-piperazinyl]butyl bridged bicyclic imides
US5053508A (en) * 1990-03-09 1991-10-01 American Home Products Corporation Fused heterotricyclic imides with psychotropic activity and intermedrates thereof
DK0482696T3 (da) * 1990-10-23 1996-05-20 Akzo Nobel Nv 4-(4- eller 6-(trifluormethyl-2-pyridinyl))-1-piperazinylalkyl-substituerede lactamer
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5459143A (en) * 1993-12-09 1995-10-17 Bayer Aktiengesellschaft N,N-disubstituted piperazines
US5409932A (en) * 1993-12-09 1995-04-25 Bayer Ag Piperazine-substituted pyrroloanthracenes
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US7468439B2 (en) 2006-09-06 2008-12-23 Bristol-Myers Squibb Company Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
WO2009059077A1 (en) 2007-11-01 2009-05-07 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1147947B (de) * 1961-07-25 1963-05-02 Knoll Ag Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
AT364852B (de) * 1977-11-05 1981-11-25 Thomae Gmbh Dr K Verfahren zur herstellung von kondensierten isothiazol-3(2h)-on-1,1-dioxiden und von deren salzen
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
HU206344B (en) 1992-10-28
GB2181730B (en) 1989-09-13
GR3002635T3 (en) 1993-01-25
EP0220051A1 (en) 1987-04-29
PT83548B (pt) 1988-10-14
AU603776B2 (en) 1990-11-29
KR900000371B1 (ko) 1990-01-25
GB2181730A (en) 1987-04-29
DE3679767D1 (en) 1991-07-18
PT83548A (en) 1986-11-01
DK495586D0 (da) 1986-10-16
AU6364286A (en) 1987-04-30
GB8624575D0 (en) 1986-11-19
DK495586A (da) 1987-04-18
US4732984A (en) 1988-03-22
ES2039200T3 (es) 1993-09-16
HUT45997A (en) 1988-09-28
CA1272197A (en) 1990-07-31
EP0220051B1 (en) 1991-06-12

Similar Documents

Publication Publication Date Title
KR870004026A (ko) 피페라지노 이소티아졸론의 제조방법
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
KR850005829A (ko) 2-시아노벤즈이미다졸 유도체의 제조방법
KR830001274A (ko) 이미다졸릴 비닐 에테르의 제조방법
KR860008158A (ko) 복소환식 화합물의 제법
FR2436150A1 (fr) Derives de 3'',4''-diacyltylosine utiles comme medicaments
KR830005110A (ko) 플루오렌 유도체의 제조방법
DK0452952T3 (da) Fremgangsmåde til fremstilling af benzylaminer
ES485593A1 (es) Un procedimiento para la produccion de un derivado de acido fenoxicarboxilico
KR850006395A (ko) 글리시딜 화합물의 제조방법
KR830007510A (ko) 심장질환 치료제의 제조방법
KR900018067A (ko) 시클릭 설페이트의 제조방법
KR830004322A (ko) 항알러지 및 항궤양제 1-옥소-1H-티아졸로 [3,2-a]피리미딘-2-카복사미드와 그의 중간물질
KR870003087A (ko) 페녹시프탈리드 유도체, 그 제조방법 및 이를 함유하는 제초 조성물
EP0466733A1 (en) METHOD FOR PRODUCING SUBSTITUTED ETHENES.
US4720552A (en) Process for the preparation of acid addition salts of 4(5)-methyl-5(4)-thiomethyl imidazole
KR960041167A (ko) 임의의 2-치환 5-클로로이미다졸-4-카르보알데히드의 제조방법
KR890002080A (ko) 퍼플루오로알킬-함유 에폭사이드 및 이의 제조방법
GB1394775A (en) Triazine compounds
KR910016673A (ko) 히드록시페닐프로피오네이트의 제조방법
EP0279161A2 (en) A process for the preparation of cimetidine
KR840003619A (ko) 메틸-치환테트라히드로-2-피리미디논 유도체와 그 중간체의 제조방법
US4389411A (en) Cyano-(2,4-dichlorophenyl)methyl ethyl ester of carbonic acid useful as a nematocide
KR870002095A (ko) 옥시구아니딘 유도체의 제조 방법
GB1347613A (en) 2-aminoquinoxalines

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19921209

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee